GDNF delivery using human neural progenitor cells in a rat model of ALS. - Wikidata - wikimedia - TriplyDB

GDNF delivery using human neural progenitor cells in a rat model of ALS.

GDNF delivery using human neural progenitor cells in a rat model of ALS.

http://www.wikidata.org/entity/Q40425197

about

Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review Real time imaging of human progenitor neurogenesis Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis Stem cells in human neurodegenerative disorders--time for clinical translation?Stem cells for the treatment of neurological disorders Protection of visual functions by human neural progenitors in a rat model of retinal disease.GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects.Human nerual stem cells for brain repair Ferumoxytol Labeling of Human Neural Progenitor Cells for Diagnostic Cellular Tracking in the Porcine Spinal Cord with Magnetic Resonance Imaging.Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord.Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats.Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.Enteric glial cells and their role in the intestinal epithelial barrier "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.Mesenchymal stem cells for the treatment of neurodegenerative disease.Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis.Differential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS.Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats.Model systems of motor neuron diseases as a platform for studying pathogenic mechanisms and searching for therapeutic agents.Neural stem cells: historical perspective and future prospects.Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke.Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice.Gene therapy: can neural stem cells deliver?New frontiers in human cell biology and medicine: can pluripotent stem cells deliver?Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies.Melittin-grafted HPMA-oligolysine based copolymers for gene delivery.Neurodegeneration and cell replacement.Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis Potential roles of bone marrow stem cells in stroke therapy.

P2860

Q26776154-42DD6351-A521-4C79-94F4-8D68BF16CCDD Q26822886-2C8C6F57-B7C1-4DFE-985B-CD043B302679 Q26825854-C0F1D118-F0B3-42B3-9CCF-FBB94AD5A575 Q26861926-DC1C64F5-4D5A-48E0-AD4E-B2F425BC9150 Q27318549-661BB1D1-C72C-49C4-B23E-A65FB4A4D999 Q27338320-87E8D0FA-D0A7-48AB-85ED-4251C87617DF Q27687068-C11E26E6-F5B3-44D3-A06F-2E38E46E0EF6 Q28249501-3D27AA3C-1328-4C9E-AA37-618AC662B36B Q33280574-65C6A2D5-E7DE-4B91-9AD7-DA6DCF2800E7 Q33292690-609A901A-6484-44D1-84BE-3EEA6940A569 Q33600773-251F407C-ED54-4703-B90E-5BF1695AD011 Q33614725-677B5B09-8D85-4D02-9DFA-B5C1403458C9 Q33722252-C37E8FB6-2135-4638-8D2F-7A0A11F47B6B Q33729764-E393084D-F8A9-453D-A211-CE10A4012CDD Q33804981-1DB85C6D-632D-42A8-B471-CFDF367DFA03 Q33858257-772E5828-BC27-4ABB-984C-0D7ABE081FD1 Q33919781-A0CFBA9B-A6DD-4039-8E25-2FC1C7B5CFAB Q34093834-9024DA3B-D9D3-40F5-83F4-0D886398BCAA Q34122934-7559BE0C-420A-49C7-9956-0AFEF553E5EB Q34222849-194D4869-671B-4D7F-A903-8C3A512C6D63 Q34276055-AC90E794-2405-4088-BE7C-22AA2B4B6203 Q34473474-AB3BCC73-1CEE-4E40-B612-7AACFF8EDCEE Q34568739-88DA3083-FB3B-478D-9571-FEF4AD38755F Q34903874-ACAA146A-8377-4795-938C-472CFFB2E366 Q34978654-6BDB4DAC-E2B1-4184-B848-43AEADF075CA Q34994432-401B74AA-7B0B-434F-8E0A-7AAA2846C867 Q35540393-AC8275B8-AD40-4C25-88AA-9584E5A4669D Q35576478-E9391A23-9066-40D2-8E83-7F042EE8286B Q35730391-F3F63D12-DA95-4E5D-BFF5-634A6D8128A9 Q36111849-CD714534-DCBB-498F-9D39-D6180F08FB07 Q36117618-B249D3A7-CCD0-40A0-A4D0-9FE2F7C82C3A Q36249538-2B650BBE-4382-48B4-9D65-6B3FEBCE8576 Q36334459-55C4701F-EA93-4DD4-B878-7549A7273B23 Q36350210-E4EDA1D7-032D-4B03-80BE-420262DFEAC0 Q36389277-EA04C0E0-49DB-44BB-8AC1-B61447D63F5F Q36419592-369A30B0-349B-4195-B1ED-73E10C3AB32F Q36553868-8C384B96-8F92-4253-AE04-C06E1391129C Q36748869-A6CD3931-4512-4DC0-985D-AC90FEECCF84 Q36816782-6A088BA6-D3AF-4A59-AD0E-5399188203E1 Q36883767-2A7B6F2F-BBFE-4CF0-9044-1F9DDE87B0B3

P2860

GDNF delivery using human neural progenitor cells in a rat model of ALS.

http://www.wikidata.org/entity/Q40425197

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

GDNF delivery using human neural progenitor cells in a rat model of ALS.

@en

type

label

GDNF delivery using human neural progenitor cells in a rat model of ALS.

@en

prefLabel

GDNF delivery using human neural progenitor cells in a rat model of ALS.

@en

P1433

Q40425197-5A6F85F6-48BF-49EC-AE1B-D46931A1A265

P1476

Q40425197-81552DD2-A0B6-4C0C-84E1-C57F9A3B3FFD

P2093

Q40425197-02239D6A-23DB-49AC-95CF-712414075E45

Q40425197-4A96F5F6-6C06-42E1-8C81-454A619BA84B

Q40425197-5709FFDB-435F-4A21-82DE-38BA2A1293AA

Q40425197-5A404AC6-BDCD-4C12-B7FC-10FA3EE7A0B9

Q40425197-600B9686-CA6B-43C1-A595-19B64A0EF91B

Q40425197-8917FF32-A346-4A64-89BA-9BE3952FE383

Q40425197-A099B7BA-E0AA-4CF3-B47E-F90E95356DB4

Q40425197-F5D07A77-4847-4553-8869-4875B9EE30E0

P304

Q40425197-AD47002E-8104-4DEC-B2F9-34D1543870FE

P31

Q40425197-CEFA37AF-788C-46F6-AA13-9DB500F3615B

P356

Q40425197-5489FCBB-2806-4A12-A29E-A9874579B8BF

P433

Q40425197-09BC48C8-6EE0-4ED1-A51F-526B1BED63A8

P478

Q40425197-B0C73B0B-08F1-4D56-9146-463F754E3B99

P577

Q40425197-126EEBB3-F1D9-47A2-A6AC-B7C69E88F89F

P698

Q40425197-C9249F83-21D1-458E-A55D-9BEBC35FF3EA

P921

Q40425197-D5E7C243-C66A-428D-B60F-BB24B92EE3A1

P356

HUM.2005.16.509

P1433

Human Gene Therapy

P1476

GDNF delivery using human neural progenitor cells in a rat model of ALS.

@en

P2093

Clive N Svendsen

http://www.w3.org/2001/XMLSchema#string

Jacalyn McHugh

http://www.w3.org/2001/XMLSchema#string

Kristin Hoffmann

http://www.w3.org/2001/XMLSchema#string

Kyle Wallace

http://www.w3.org/2001/XMLSchema#string

Masatoshi Suzuki

http://www.w3.org/2001/XMLSchema#string

Patrick Aebischer

http://www.w3.org/2001/XMLSchema#string

Sandra M Klein

http://www.w3.org/2001/XMLSchema#string

Soshana Behrstock

http://www.w3.org/2001/XMLSchema#string

P304

509-521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2005.16.509

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15871682

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis